A B S T R A C T Circulating human lymphocytes freshly isolated from venous blood of 15 normal subjects exhibited a low capacity to bind, take up, and degrade 125I-labeled low density lipoprotein (LDL). However, when these cells were incubated for 72 h in the absence of lipoproteins, they gradually acquired an increased number of high affinity cell surface receptors for LDL. The increase in the number of LDL receptors was associated with a 16-fold increase in the rate at which the cells were able to take up and degrade the lipoprotein. The LDL binding and degradation processes that developed in normal lymphocytes exhibited the following characteristics: (a) high affinity (saturation was achieved at LDL concentrations below 50,g protein/ml); (b) specificity (unlabeled LDL was much more effective than human high density lipoprotein or other plasma proteins in competing with 125I-LDL for binding to the LDL receptor); and (c) feedback regulation (the increase in the number of LDL receptors that appeared after incubation of freshly isolated lymphocytes in lipoprotein-deficient medium was prevented by exposure of the cells to either LDL or a mixture of 25-hydroxycholesterol plus cholesterol but not to HDL).
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Freshly isolated lymphocytes obtained from three subjects with the homozygous form of familial hypercholesterolemia failed to develop normal amounts of LDL receptor activity when incubated in medium devoid of lipoproteins. The current data indicate: (a) that the LDL receptors that appear on the surface of cholesterol-deprived, normal human lymphocytes are genetically identical to the previously charDr. Ho is the recipient of a National Institutes of Health INTRODUCTION Recent studies in cultured human fibroblasts have led to the hypothesis that nonhepatic cells in the body utilize a cell surface receptor to derive cholesterol for membrane synthesis from the major cholesterolcarrying protein in human plasma, low density lipoprotein (LDL)l (1) . In fibroblasts this receptor shows high affinity and specificity for LDL (2) (3) (4) (5) . Once bound to the receptor, LDL is internalized and delivered to lysosomes where both its protein and cholesteryl ester components are hydrolyzed by acid hydrolases (3, (6) (7) (8) . The resultant free cholesterol is then able to leave the lysosome and gain access to the extralysosomal cellular compartment where it is utilized for membrane synthesis (9, 10) . The emergence of this LDL-derived cholesterol from the lysosome regulates three events in cholesterol metabolism: (a) it reduces endogenous cholesterol synthesis by suppressing the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoA reductase) (11); (b) it stimulates its own reesterification and storage as cholesteryl esters by activating an acyl-CoA:cholesterol acyltransferase (12, 13) ; and (c) it prevents an excessive uptake of LDL-cholesterol by suppressing the synthesis of the cell surface LDL receptor (14) . In addition to cultured fibroblasts, this pathway for LDL metabolism has recently been shown ' Abbreviations used in this paper: DMPA, N,N-dimethyl-1,3-propanediamine; FH, familial hypercholesterolemia, HDL, high density lipoprotein; HMG CoA reductase, 3- t Determined in cultured fibroblasts bv previously described criteria (17, 30) . § An end-to-side portacaval shhunt was performed 19 mo before the cutrrent sttudies (31) .
to be present in cultured long-termi humilani lymphoid cells (15, 16) . In both fibroblasts (2) (3) (4) (5) 17) and lvmphoid cells (16) cultured from patients with the receptor-negative form of homozygous familial hypercholesterolemia (FH), the cell surface LDL receptor is functionally absent. As a result, these mutanit cells are unable to bind, internalize, or degrade LDL witlh high affinity, they caninot utilize the lipoprotein's cholesterol for membrane synthesis, and they are therefore resistant to the regulatory actions of LDL on cholesterol metabolism (1, 17) .
The delineation of the LDL pathway in cultuired fibroblasts and cultured lvmphoid cells depended on the ability to induce maxiimal synthesis of the LDL receptor by growing the cells in the absence of an exogenous source of cholesterol so that they develop an enhanced requirement for the sterol (1, 14) . On the other hand, when fibroblasts and lymphoid cells are exposed continuously to LDL, as when grown in the presence of whole sertum, these cells establish a steady state in which they exhibit a low number of LDL receptors that is just sufficient to provide the cells with enough cholesterol to balan-ce cellular losses that occur as a result of membrane turnover (1, 9, 14) . In general, this steady-state number of LDL receptors is less than 20% of the maximal number that the cells are capable of synthesizing after they have been deprived of cholesterol for an extended period (14) . Since most cells in the body are continuously exposed to LDL and are hence never deprived of cholesterol (18, 19) , it seems likely that in the steady state cells in the body will manifest only a small fraction of their maximal number of LDL receptors (1 (2) . The svnthesis of cationized 1251-LDL (125I-DMPA-LDL) and of cationized 1251-albumin (125I-DMPAalbumin) was performed as previously described with N,Ndimethyl-1,3-propanediamine (DNIPA) as the tertiary amine derivative (22) . Isolation of lymphocytes. Peripheral blood lymphocvtes were isolated under sterile conditions at room temperature by a modification of the method of Bovuim (23) . Venous blood from each subject (20-100 ml) was obtained after an overnight fast and was drawn into a heparin solution (100 U heparin/10 ml blood). The blood was immediately diluted with an equal volume of 0.15 M NaCI, and each 20 ml of the resulting blood-NaCl mixture was layered onto 10 ml of Lymphoprep contained within one 50 ml plastic conical tube. The tubes were centrifuged at 1,400 rpm for 40 min. The interphase material containing the mononuclear cells (6) (7) (8) Binding of 125I-LDL by intact lymphocytes at 4°C. Lymphocytes from the stock flasks were harvested by centrifugation (1,200 rpm, 10 min, 4°C), washed once in 6 ml of buffer B (Dulbecco's phosphate-buffered saline containing 50 ,uM CaCl2 and 20 mg/ml bovine serum albumin), and resuspended in ice-cold buffer B at a final concentration of about 50 x 106 cells/mIl. Aliquots of this cell suspension (75 j1l containing about 4 x 106 cells and 160-280 ,ug total cell protein) were placed in a 400 gl polvethylene microfuge tube in a final volume of 100 ,ll of buffer B.
The indicated concentration of freshly filtered 125I-LDL (16) was added in the presence or absence of excess unlabeled LDL, and the cells were incubated for 30 min at 40C, after which the cells were collected by centrifugation, washed as previously described for cultured human longterm lymphoid cells, and the total amount of I251-LDL bound to the cells was determined (16) . All of the above additions and centrifugations were carried out in a 4°C cold room. Total binding of 125I-LDL represents the amount of 125I_ LDL bound to the cells in the absence of excess unlabeled LDL. High affinity binding is that component of the total that was inhibited competitively by the presence of an excess of unlabeled LDL.
Cellular accumulation and proteolytic degradation of 1251_ LDL by intact lymphocytes at 37°C. Aliquots of lymphocytes from the stock flasks (2 ml of medium containing about 4 x 106 cells) were transferred to 30-ml flasks. 1251_ LDL was added in the presence or absence of excess unlabeled LDL and the cells were incubated at 37°C for the indicated interval, after which the cells and medium were separated by centrifugation (1700 rpm, 5 min, 4°C). The medium was then treated with trichloroacetic acid to a final concentration of 10%o (vol/vol), after which the precipitate was removed by centrifugation and the supernate was treated with hydrogen peroxide and extracted with chloroform to remove free iodine (24) . An aliquot of the aqueous phase was counted to determine the amount of 125I-labeled acid-soluble material formed by the cells and released to the medium (3). Degradation activity is expressed as nanograms of 125I-LDL protein degraded to acid-soluble material per milligram of cell protein. A blank value due to the presence of small amounts of acid-soluble material (<0.1% of total added radioactivity) in the '251-LDL preparation wvas routinely determined at the appropriate concentration ofthe lipoprotein by incubation at 37°C in medium containing no cells (3, 16) . Total degradation of 125I-LDL represents the amount of 125I-LDL degraded in the absence of excess unlabeled LDL. High affinity degradation is that component of the total that was inhibited competitively by the presence of an excess of unlabeled LDL. The total cellular content of 125I-LDL (i.e., the 125I-LDL contained both at the receptor site on the cell surface and within the cell) was determined from the cell pellet with the washing procedure previously described for cultured human long-term lymphoid cells (16) . The cellular content of I251-LDL is expressed as the nanograms of '25I-LDL protein bound to the cell per milligram of total cell protein.
Other assay. The content of protein was determined by a modification of the method of Lowrv et al. (25) , by using bovine serum albumin as a standard.
RESULTS
To assay for high affinity cell surface LDL binding activity in human lymphocytes, the cells were incubated at 40C with low concentrations of 125I-LDL either in the absence or presence of a 25-fold excess of unlabeled LDL. The amount of 125I-LDL bound to the cell membrane was then measured by using a washing technique that was previously developed for assay of 125I-LDL binding in human lymphoid cells maintained in long-term culture (16) . In this type of competition assay, the high affinity binding is defined as the amount of 1251-LDL that is prevented from binding to the cell membrane by the excess of unlabeled LDL (i.e., the difference between the 125I-LDL binding obtained in the absence and presence of unlabeled LDL). When freshlys isolated humani lymphocytes obtained from a normal subject were incubated with 125I-LDL at 4°C, relatively little high affinity binding was observed (Fig. 1, zero Fig. 1 was repeated by using lymphocytes isolated from a different normal subject (E.S., a 29-yr-old female). During the 96-h incubation, the number of lymphocytes in each flask remained constant, and there was no change in the morphologic appearance of the cells. Fig. 2 shows that the high affinity binding activity that developed in normal lymphocytes after incubation for 72 h in medium devoid of lipoprotein was relatively specific for LDL. Thus, when pre- (Fig. 1) , they also were acquiring an increased ability to degrade 125I-LDL (Fig. 3) . Fig. 4 shows the time course of metabolism of 125I-LDL at 37°C by the high affinity process in normal lymphocytes that had been incubated for 72 h in medium devoid oflipoproteins. As previously observed for cultured human fibroblasts (3, 4) and cultured human lymphoid cells (16) , the cellular content of 125I-LDL rose and reached a steady-state plateau at about 2 h (Fig. 4A) , while the rate of degradation of 125I-LDL continued in a nearly linear fashion for 8 h (Fig. 4B) . In the presence of excess unlabeled LDL, both the uptake of 125I-LDL and its rate of degradation were reduced proportionately.
The saturation curve for 125I-LDL degradation is shown in Fig. 5 . As previously observed in cultured fibroblasts (3, 7) , the LDL concentration curve in normal lymphocytes consisted of two components, a high affinity component that reached saturation at an LDL concentration of about 50 jig protein/ml and (hours) FIGURE 3 Increase in the ability of normal lymphocytes to degrade 125I-LDL after incubation in the absence of lipoproteins. Lymphocytes were isolated from. 80 ml of venous blood obtained from a healthy 32 yr-old female (V. J.), and four replicate stock flasks were prepared as described in Methods. The cells were incubated at 37°C in medium A containing l1o0 lipoprotein-deficient serum. At each indicated interval, the cells and medium from one flask were divided into six 2-ml aliquots. Each 2 ml aliquot was transferred to a 30-ml flask, after which was added 10 ug protein/ml of 125I-LDL (265 cpm/ng) either in the presence (0) or absence (0) of 250 ug protein/ml of unlabeled LDL.
The flasks were incubated at 37°C for 6 h, after which the cells were removed by centrifugation and the content of l25I-labeled acid-soluble material in the medium was determined as described under Methods. an apparently nonsaturable component that caused the rate of degradation to increase slightly in a linear fashion at LDL concentrations above 50 ,ug protein/ ml. As with high affinity 125I-LDL binding at 4°C (Fig. 2) , the rate of degradation of 125I-LDL at 37°C was competitively inhibited by LDL, whereas HDL was much less effective (Fig. 6) . Considered together, the data in Figs. [1] [2] [3] [4] [5] [6] suggest that circulating normal lymphocytes incubated in the absence of lipoproteins acquire an increased number of specific, high affinity LDL receptors and that these receptors facilitate the uptake and degradation of LDL in a manner similar to that previously observed in cultured human fibroblasts and cultured human lymphoid cells. In human fibroblasts the induction of LDL receptors has been shown to be a consequence of the removal of the cells from an exogenous source of cellular cholesterol (14) . That a similar mechanism was also responsible for the induction of LDL receptors in circulating lymphocytes is indicated by the data in Table II To test the specificity of the effect of LDL and the mixture of sterols in preveniting the enhanieement of the receptor-mediated degradation of "251-LDL, the ability of the incubated lymphocytes to degrade 1251_ DMPA-albumin was examined. We have previouisly shown that in fibroblasts 125I-DNIPA-albumin, which has a strong positive charge, binds avidlv to negatively-charged sites on the cell sturface and is then taken up by cells and degraded in lysosomes (22) . Thus, 125I-DMPA-albumin serves as a good marker for the overall rate of celltular endocytosis and lysosomal proteolysis.2 As shown in Table II , neither LDL itself nor the mixture of 25-hydroxycholesterol and cholesterol suppressed the degradation of 1251-DMPAalbumin in incubated lymphocytes under conditions in which the degradation of 125I-LDL was redtuced by more than 10-fold.
In other experiments not shown, normal lymphocytes that had been incubated for 72 h in the absence of lipoproteins degraded '25I-LDL at a rate that was sixfold faster than that observed in freshly isolated, unin-cubated cells. In the same cells, however, there was no increase in the rate of degradation of 125I-DMPA-LDL, a macromolectile that, like 125I-DMPA-albumin, gains entry to cellutlar lysosomes by binding Inon1-specifically to negatively-charged sites on the cell surface rather thain l)y )inding to the LDL receptor (22) .
To determine whether the LDL receptor that appeared in freshly isolated lymphocytes was genetically the sanme as the LDL receptor previously characterized in cuilttured fibroblasts and long-term lymviphoid cells, we comppared the appearance of LDL receptor activity in cells from nornmal subjects and from patients with the homozygous form of FH. Table III protein/ml of unlabeled LDL, or 100 ,jg protein/ml of unlabeled HDL). After incubation at 37°C for 72 h, the cells from each flask were harvested by centrifugation (1,000 rpm, 10 min, 24°C), washed in 15 ml of medium A containing 10%o human lipoprotein-deficient serum, and recentrifuged. Each cell pellet was then resuspended in 12.5 ml of medium A containing 10% human lipoprotein-deficient serum and the resulting suspension of cells was equally divided into six 2-ml aliquots. Each 2 ml aliquot was transferred to a 30-ml flask, after which was added either 7.3 ,ug/ml of l25I-DMPA-albumin (Exp. A, 664 cpm/ng; Exp. B, 559 cpm/ng) or 10 ,ug protein/ml of 1"I-LDL (Exp. A, 369 cpm/ng; Exp. B, 178 cpm/ng) in the presence or absence of 250 ,pg protein/ml of unlabeled LDL. After incubation at 37°C for 6 h, the medium and cells from each flask were separated, after which the content of 125I-labeled acid-soluble material in the medium was determined as described under (2) (3) (4) 14) and lymphoid cells (16) Two lines of evidence excluded the possibility that the low number of LDL receptors in freshly isolated lymphocytes was a result of damage to the cells during their isolation. First, the isolation procedure did not reduce the ability of the cells to degrade cationized LDL (DMPA-LDL). And second, the appearance of receptor sites could be specifically blocked by inclusion of low levels of LDL in the 72-h incubation mixture. It was also possible, at least in theory, that the low level of receptor activity in the freshly isolated lymphocytes was due to occupancy of the receptor sites by LDL to which the cells had been exposed in the blood stream. However, we have previously shown in both cultured human fibroblasts and lymphoid cells that all receptor-bound LDL is internalized within 7 min at 37°C and that this internalization leads to the regeneration of the original number of unoccupied receptor sites (3, 4, 14, 16) . In the present studies the degradation experiments were carried out for 6 h at 37°C, an interval that is far in excess of the time required for prebound plasmiia LDL to be cleared from the receptor sites. This coniclusion is supported bv the data in Tables III and  IV . In the normal cells that had been incubated for 72 h in the absence of lipoproteins, the rate of high affinity degradation of 125I-LDL was 631 ng mg-' 6 h-1, which is equal to 1.75 ng mg-' min- (Table IV) . Under these conditions the surface binding of 125I-LDL was 14 ng/mg (Table III) (4) .
A point worthy of discussion is the difference in sensitivity between the two assays used to measure the function of the LDL receptor in lymphocytes, namely the measurement ofhigh affinity binding at 4°C and the measurement of the rate of high affinity degradation at 37°C. The binding assay is stoichiometric. That is, the number of particles of 125I-LDL bound to the cells is equal to the number of LDL receptors. On the other hand, the degradation assay is equivalent to a catalytic assay for the LDL receptor. That is, the number of 1251_ LDL particles degraded is equal to many times the number of receptor molecules since each receptor internalizes many particles of LDL during the usual 6 h incubation. Because of this amplification effect, the assay for high affinity degradation gives values that are many fold higher than the background. On the other hand, the assay for high affinity surface binding is less discriminative at low receptor levels. Thus, as shown by the data in Table IV , in the freshly isolated lymphocytes obtained from normal subjects the degradation assay was sensitive enough to reveal detectable amounts of high affinity 125I-LDL degradation, a finding that implies the presence of small amounts of high affinity 125I-LDL binding and uptake. However, as shown by the data in Table III , this amount of receptor activity in nonincubated cells was not sufficiently large to be reliably distinguished from the blank value when 1251I-LDL binding was measured directly at 4°C.
The current data indicate that at least one type of cell in the human body, the circulating lymphocyte, has the capacity to produce a high affinity LDL receptor that enables the cell to take up and degrade 125I-LDL. The data further indicate that this capacity is only partially expressed in the steady state in vivo. Since suppression of LDL receptor activity can be maintained in vitro by a continuous exposure of the lymphocytes to LDL and since in vivo lymphocytes are normally exposed to a high level of LDL in the circulation, it is reasonable to suppose that the suppression of LDL receptor activity in vivo is due to the presence of plasma LDL. By analogy to the situation in cultured human fibroblasts (1, 14) , it seems likely that the small number of LDL receptors that are normally present on circulating lymphocytes are sufficient to supply all of the cholesterol requirements of these cells so long as they are continuously exposed to LDL. It is only after lymphocytes are deprived of cholesterol that they develop a sterol deficit and hence begin to synthesize high levels of LDL receptors.
The demonstration that the LDL receptor in freshly isolated lymphocytes does in fact function to regulate cellular cholesterol homeostasis as in cultured human fibroblasts and long-term lymphoid cells will require further studies relating LDL receptor activity to the processes ofcholesterol synthesis and cholesteryl ester formation in these cells. That such a correlation may indeed exist is suggested by studies of Fogelman et al. (26, 27) Higgins et al. (28) , and Williams and Avigan (29) , who have shown that mixed human leukocytes develop an enhanced rate of cholesterol synthesis when incubated in vitro in the absence of lipoproteins.
